94 related articles for article (PubMed ID: 20156936)
1. Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?
Kleijn L; de Boer RA; Voors AA
Eur J Heart Fail; 2010 Mar; 12(3):215-6. PubMed ID: 20156936
[No Abstract] [Full Text] [Related]
2. Use of erythropoietin in heart failure management.
Caiola K; Cheng JW
Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
[TBL] [Abstract][Full Text] [Related]
3. Anemia in chronic heart failure: should we treat it and how?
Komajda M
J Am Coll Cardiol; 2007 Feb; 49(7):763-4. PubMed ID: 17306704
[No Abstract] [Full Text] [Related]
4. Erythropoiesis-stimulating agents in kidney and cardiac disease.
Fluck R
Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130
[No Abstract] [Full Text] [Related]
5. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
[TBL] [Abstract][Full Text] [Related]
6. Post transplantation anemia: re-emphasizing the use of erythropoietin.
Jabur WL
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):104-6. PubMed ID: 21196622
[No Abstract] [Full Text] [Related]
7. Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents.
Lawler PR; Filion KB; Eisenberg MJ
J Card Fail; 2010 Aug; 16(8):649-58. PubMed ID: 20670844
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and heart failure: the end of a promise?
Kleijn L; Westenbrink BD; van der Meer P
Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
[No Abstract] [Full Text] [Related]
9. The etiology of anemia in heart failure. Preface.
Agarwal AK; Katz SD; Singh AK
Heart Fail Clin; 2010 Jul; 6(3):xvii-xviii. PubMed ID: 20630400
[No Abstract] [Full Text] [Related]
10. Clarifying the use of erythropoietic agents.
Smith RE
J Support Oncol; 2004; 2(3):200, 202; author reply 202. PubMed ID: 15328822
[No Abstract] [Full Text] [Related]
11. [Comorbidity: anemia and heart failure].
Mahfoud F; Kindermann I; Kindermann M; Ukena C; Böhm M
Dtsch Med Wochenschr; 2009 Apr; 134(16):825-30. PubMed ID: 19353467
[No Abstract] [Full Text] [Related]
12. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
Henry DH; Bowers P; Romano MT; Provenzano R
Arch Intern Med; 2004 Feb; 164(3):262-76. PubMed ID: 14769622
[TBL] [Abstract][Full Text] [Related]
13. Darbapoetin alfa does not help adults with heart failure and anaemia.
BMJ; 2013 Mar; 346():f1626. PubMed ID: 23487165
[No Abstract] [Full Text] [Related]
14. A meta-analysis of erythropoiesis-stimulating agents in anaemic patients with chronic heart failure.
Jin B; Luo X; Lin H; Li J; Shi H
Eur J Heart Fail; 2010 Mar; 12(3):249-53. PubMed ID: 20031949
[TBL] [Abstract][Full Text] [Related]
15. Treatment of anemia in chronic kidney disease--strategies based on evidence.
Marsden PA
N Engl J Med; 2009 Nov; 361(21):2089-90. PubMed ID: 19880845
[No Abstract] [Full Text] [Related]
16. Finding a rational approach to ESA therapy--for payers and patients.
Messana A
Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
[No Abstract] [Full Text] [Related]
17. Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".
Belonje AM; de Boer RA; Voors AA
Cardiovasc Drugs Ther; 2008 Feb; 22(1):1-2. PubMed ID: 18219567
[No Abstract] [Full Text] [Related]
18. [Anemia as complication of chronic heart failure: prevalence, treatment, prognosis].
Tereshchenko SN; Atroshchenko ES; Uskach TM; Kudinova AA; Riabinina MN
Ter Arkh; 2008; 80(9):90-5. PubMed ID: 19555048
[No Abstract] [Full Text] [Related]
19. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
Vaziri ND; Zhou XJ
Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
[No Abstract] [Full Text] [Related]
20. Reevaluating erythropoiesis-stimulating agents.
Kimmel PL; Malozowski S
N Engl J Med; 2010 May; 362(18):1742-3; author reply 1743-4. PubMed ID: 20449880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
